Page last updated: 2024-10-30

lamotrigine and Batten Turner Congenital Myopathy

lamotrigine has been researched along with Batten Turner Congenital Myopathy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Stunnenberg, BC1
LoRusso, S1
Arnold, WD1
Barohn, RJ1
Cannon, SC1
Fontaine, B1
Griggs, RC1
Hanna, MG1
Matthews, E1
Meola, G1
Sansone, VA1
Trivedi, JR1
van Engelen, BGM1
Vicart, S1
Statland, JM1
Andersen, G1
Hedermann, G1
Witting, N1
Duno, M1
Andersen, H1
Vissing, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
High Intensity Interval Training in Patients With Facioscapulohumeral Muscular Dystrophy[NCT02159963]18 participants (Actual)Interventional2014-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for lamotrigine and Batten Turner Congenital Myopathy

ArticleYear
Guidelines on clinical presentation and management of nondystrophic myotonias.
    Muscle & nerve, 2020, Volume: 62, Issue:4

    Topics: Acetazolamide; Age of Onset; Carbonic Anhydrase Inhibitors; Chloride Channels; Electrodiagnosis; Ele

2020

Trials

1 trial available for lamotrigine and Batten Turner Congenital Myopathy

ArticleYear
The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study.
    Brain : a journal of neurology, 2017, Sep-01, Volume: 140, Issue:9

    Topics: Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Huma

2017